Innocan Pharma's BI Sky Global Achieves HRIPT Testing Completion and Daily Sales Milestone#USA#Calgary#Innocan_Pharma#BI_Sky_Global#HRIPT_Testing
Innocan Pharma's BI Sky Global Achieves HRIPT Testing Completion and Daily Sales Milestone
Innocan Pharma's subsidiary BI Sky Global has completed crucial HRIPT testing and reached a remarkable sales target of 5,000 units daily in 2024.
third-news.com
January 29, 2025 at 9:08 PM
Innocan Pharma's BI Sky Global Achieves HRIPT Testing Completion and Daily Sales Milestone#USA#Calgary#Innocan_Pharma#BI_Sky_Global#HRIPT_Testing